Jeffrey Gosslee, MD
Retina Specialist · Shreveport, LANPI 1356320568
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $255 of the $289 with a category attached, or 88.2%. Regeneron Healthcare Solutions, Inc. accounts for 60.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $99 and has fallen 84.8% since, to $15 in 2025. That places this record below the midpoint for retina specialist clinicians in LA, where the typical reported total is $2,679.
Across 13 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$175
- Bausch & Lomb, A Division Of Bausch Health US, LLC$39
- Alcon$22
- Eyepoint US, Inc.$20
- Carl Zeiss Meditec AG$19
- Genentech USA, Inc.$13
What the payments were for
- Food & beverage$25588%
- Education$155%
- Gifts$197%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $175 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $39 |
| Alcon | 1 | $22 |
| Eyepoint US, Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$289 in reported general payments places this provider in the 10th percentile of 30 retina specialist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 139 | $3,695 |
| Bromfenac Sodium | 15 | $3,287 |
| Ketorolac Tromethamine | 131 | $2,109 |
| MoxifloxacinMoxifloxacin Hcl | 42 | $833 |
| Atropine Sulfate | 30 | $710 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 25 | $507 |
| Brimonidine Tartrate | 38 | $308 |
| Latanoprost | 17 | $230 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $168 |
| Timolol Maleate | 16 | $109 |
| Prednisone | 27 | $54 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Shreveport
- Charles LyonShreveport$802
- Morgan MorganShreveport$56
- Donald MazzullaNew Orleans$215K
- Sidharth PuriNew Orleans$32K
- Gwen CousinsMetairie$10K
- Frank CulottaLafayette$9K
- Adam JanotBaton Rouge$8K
- Daniel SalisburyBaton Rouge$7K
- Scott GauthreauxLafayette$7K
- Brett BuddenMetairie$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.